1. Home
  2. MRVI vs DCBO Comparison

MRVI vs DCBO Comparison

Compare MRVI & DCBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.67

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Logo Docebo Inc.

DCBO

Docebo Inc.

HOLD

Current Price

$19.06

Market Cap

489.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
DCBO
Founded
2014
2016
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
472.8M
489.9M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
MRVI
DCBO
Price
$3.67
$19.06
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$4.57
$32.00
AVG Volume (30 Days)
1.1M
270.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
14.29
N/A
EPS
N/A
N/A
Revenue
$185,743,000.00
N/A
Revenue This Year
$11.80
$12.54
Revenue Next Year
$7.74
$11.82
P/E Ratio
N/A
$22.04
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$16.07
52 Week High
$4.11
$33.69

Technical Indicators

Market Signals
Indicator
MRVI
DCBO
Relative Strength Index (RSI) 62.09 54.98
Support Level $3.65 $18.11
Resistance Level $4.03 $20.15
Average True Range (ATR) 0.18 0.97
MACD 0.09 0.26
Stochastic Oscillator 78.64 86.72

Price Performance

Historical Comparison
MRVI
DCBO

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

Share on Social Networks: